Healthcare provider profile · identity verified

Bruce Sheaffer Cohick, MD

Family Practice · HARRISBURG, PA · NPI 1639138076

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	744	226
Amlodipine Besylate	Amlodipine Besylate	558	172
Levothyroxine Sodium	Levothyroxine Sodium	376	101
Metoprolol Succinate	Metoprolol Succinate	339	105
Rosuvastatin Calcium	Rosuvastatin Calcium	322	109
Pantoprazole Sodium	Pantoprazole Sodium	310	101
Pravastatin Sodium	Pravastatin Sodium	278	87
Lisinopril	Lisinopril	271	98
Hydrochlorothiazide	Hydrochlorothiazide	218	73
Metformin Hcl Er	Metformin Hcl	211	61
Metformin Hcl	Metformin Hcl	192	61
Sertraline Hcl	Sertraline Hcl	176	58
Omeprazole	Omeprazole	175	48
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	175	47
Lorazepam	Lorazepam	170	60
Glimepiride	Glimepiride	152	49
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	149	50
Tamsulosin Hcl	Tamsulosin Hcl	149	48
Eliquis	Apixaban	146	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	143	34
Gabapentin	Gabapentin	141	53
Jardiance	Empagliflozin	141	37
Valsartan	Valsartan	135	45
Doxazosin Mesylate	Doxazosin Mesylate	134	39
Montelukast Sodium	Montelukast Sodium	133	36
Losartan Potassium	Losartan Potassium	126	43
Simvastatin	Simvastatin	114	41
Furosemide	Furosemide	112	42
Oxycodone Hcl	Oxycodone Hcl	112	18
Famotidine	Famotidine	108	38
Metoprolol Tartrate	Metoprolol Tartrate	108	33
Trulicity	Dulaglutide	102	22
Escitalopram Oxalate	Escitalopram Oxalate	95	30
Ozempic	Semaglutide	95	20
Trazodone Hcl	Trazodone Hcl	88	34
Bupropion Xl	Bupropion Hcl	87	27
Clopidogrel	Clopidogrel Bisulfate	86	26
Synthroid	Levothyroxine Sodium	85	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	84	14
Potassium Chloride	Potassium Chloride	78	29
Telmisartan	Telmisartan	78	22
Meloxicam	Meloxicam	77	26
Mirtazapine	Mirtazapine	73	29
Chlorthalidone	Chlorthalidone	67	20
Ezetimibe	Ezetimibe	66	23
Hydralazine Hcl	Hydralazine Hcl	65	17
Albuterol Sulfate Hfa	Albuterol Sulfate	64	40
Mounjaro	Tirzepatide	63	14
Duloxetine Hcl	Duloxetine Hcl	61	21
Tramadol Hcl	Tramadol Hcl	58	22
Doxycycline Hyclate	Doxycycline Hyclate	56	47
Fenofibrate	Fenofibrate Nanocrystallized	56	16
Venlafaxine Hcl Er	Venlafaxine Hcl	54	16
Alprazolam	Alprazolam	51	16
Breo Ellipta	Fluticasone/Vilanterol	47	12
Xarelto	Rivaroxaban	47	15
Atenolol	Atenolol	46	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	14
Allopurinol	Allopurinol	43	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	18
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	42	12
Celecoxib	Celecoxib	41	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	21
Carvedilol	Carvedilol	36	13
Prednisone	Prednisone	35	27
Ramipril	Ramipril	35	11
Valacyclovir	Valacyclovir Hcl	35	13
Clonazepam	Clonazepam	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	31
Pregabalin	Pregabalin	31	11
Bumetanide	Bumetanide	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Incruse Ellipta	Umeclidinium Bromide	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Amoxicillin	Amoxicillin	27	20
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Xtampza Er	Oxycodone Myristate	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	12
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Tradjenta	Linagliptin	26	suppressed
Betamethasone Valerate	Betamethasone Valerate	25	12
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Fentanyl	Fentanyl	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	14
Warfarin Sodium	Warfarin Sodium	24	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Cephalexin	Cephalexin	22	16
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Jantoven	Warfarin Sodium	21	suppressed
Nystatin	Nystatin	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Finasteride	Finasteride	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Nitroglycerin	Nitroglycerin	18	13
Colchicine	Colchicine	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Nadolol	Nadolol	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	13
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Zenpep	Lipase/Protease/Amylase	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	11	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Metolazone	Metolazone	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error